An atlas of active enhancers across human cell types and tissues
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers. We further explore the utility of enhancer redundancy, which explains gene expression strength rather than expression patterns. The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation. Using the FANTOM5 CAGE expression atlas, the authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify over 40,000 enhancer candidates from over 800 human cell and tissue samples across the whole human body. FANTOM5 (standing for functional annotation of the mammalian genome 5) is the fifth major stage of a major international collaboration that aims to dissect the transcriptional regulatory networks that define every human cell type. Two Articles in this issue of Nature present some of the project's latest results. The first paper uses the FANTOM5 panel of tissue and primary cell samples to define an atlas of active, in vivo bidirectionally transcribed enhancers across the human body. These authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify more than 40,000 enhancer candidates from over 800 human cell and tissue samples. The enhancer atlas is used to compare regulatory programs between different cell types and identify disease-associated regulatory SNPs, and will be a resource for studies on cell-type-specific enhancers. In the second paper, single-molecule sequencing is used to map human and mouse transcription start sites and their usage in a panel of distinct human and mouse primary cells, cell lines and tissues to produce the most comprehensive mammalian gene expression atlas to date. The data provide a plethora of insights into open reading frames and promoters across different cell types in addition to valuable annotation of mammalian cell-type-specific transcriptomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although enriched, histone modification and cofactor binding is not completely predictive of enhancer activity54,58,72,77,105.”
From Towards a comprehensive catalogue of validated and target-linked human enhancers (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The majority of active enhancers are themselves transcribed, producing enhancer RNAs (eRNAs) in a bi-directional manner [73–77].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of their sequence properties, enhancers and promoters tend to differ in GC content, with many promoters and only a subset of enhancers containing CpG islands [74, 249].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“We filtered intragenic CAGE TCs with GG-initiation and those overlapping with coding exons and annotated enhancers24,70”
From Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes (2023) · cites this paper as [24]
In the citing paper
“as regulatory elements are subject to positive selection pressure, we identified sequences showing the highest conservation across mammalian species, including humans25–29.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Cited by
Items 201–300 of 1,017
Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity
Casellas, R., Basu, U., Yewdell, W. T., Chaudhuri, J., Robbiani, D. F., & Di Noia, J. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.2 · Cited by 186
Genome-wide mapping of transcriptional enhancer candidates using DNA and chromatin features in maize
Oka, R., Zicola, J., Weber, B., Anderson, S. N., Hodgman, C., Gent, J. I., Wesselink, J.-J., Springer, N. M., Hoefsloot, H. C. J., Turck, F., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1273-4 · Cited by 185
“RNA-seq libraries were prepared with the NEBNext Ultra ™ Directional RNA Library Prep Kit for Illumina sequencing (New England Biolabs).”
InfluentialNetwork Medicine in the Age of Biomedical Big Data
Sonawane, A. R., Weiss, S. T., Glass, K., & Sharma, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00294 · Cited by 186
“The Riken-led Functional ANnoTation Of Mammalian Genome (FANTOM5) (Andersson et al., 2014) project provided cell-type-specific enhancer elements and identified pathobiological regulatory SNPs.”
BackgroundRon, G., Globerson, Y., Moran, D., & Kaplan, T. (2017) · Nature Communications · doi:10.1038/s41467-017-02386-3 · Cited by 184
“…μ and standard deviation ! can be written as: These could be obtained using various methods, including the directionality index (DI) HMM-based method of Dixon et al (Andersson et al. 2014), or approximated iteratively using the Expectation-119 Maximization (EM) algorithm (Dempster et al. 1977).”
MethodLink, V. M., Duttke, S. H., Chun, H. B., Holtman, I. R., Westin, E., Hoeksema, M. A., Abe, Y., Skola, D., Romanoski, C. E., Tao, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.018 · Cited by 182
In search of the determinants of enhancer–promoter interaction specificity
van Arensbergen, J., van Steensel, B., & Bussemaker, H. J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.004 · Cited by 182
“Adding to the complexity, a ChIA-PET survey of loci bound by RNA polymerase II found that promoters often interact with other promoters; some of these promoters are able to act as enhancers for their partner promoter, suggesting regulatory cross-talk between promoters resembling enhancer– promoter interactions [19].”
BackgroundInfluentialHormozdiari, F., Gazal, S., van de Geijn, B., Finucane, H. K., Ju, C. J.-T., Loh, P.-R., Schoech, A., Reshef, Y., Liu, X., O’Connor, L., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0148-2 · Cited by 179
Enhancers in disease: molecular basis and emerging treatment strategies
Claringbould, A., & Zaugg, J. B. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.07.012 · Cited by 181
RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation
Rahnamoun, H., Lee, J., Sun, Z., Lu, H., Ramsey, K. M., Komives, E. A., & Lauberth, S. M. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0102-0 · Cited by 178
Werner, M. S., & Ruthenburg, A. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.033 · Cited by 177
“Notably, ‘‘strong enhancers’’ are partially defined by high levels of H3K4me3 (Ernst et al., 2011) hinting that they might generally promote expression of cheRNAs, consistent with a recent unifying model of regulatory elements (Andersson et al., 2015).”
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
Mitchell, J. S., Li, N., Weinhold, N., Försti, A., Ali, M., van Duin, M., Thorleifsson, G., Johnson, D. C., Chen, B., Halvarsson, B.-M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12050 · Cited by 180
Zhu, B., Zhang, W., Zhang, T., Liu, B., & Jiang, J. (2015) · The Plant Cell · doi:10.1105/tpc.15.00537 · Cited by 175
Liu, M., Zhou, J., Liu, X., Feng, Y., Yang, W., Wu, F., Cheung, O. K.-W., Sun, H., Zeng, X., Tang, W., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317257 · Cited by 176
Nojima, T., Tellier, M., Foxwell, J., Ribeiro de Almeida, C., Tan-Wong, S. M., Dhir, S., Dujardin, G., Dhir, A., Murphy, S., & Proudfoot, N. J. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.011 · Cited by 173
“As with other lncRNA classes, eRNAs are inefficiently spliced and in general lack consensus splicing signals (Andersson et al., 2014).”
BackgroundA high resolution atlas of gene expression in the domestic sheep (Ovis aries)
Clark, E. L., Bush, S. J., McCulloch, M. E. B., Farquhar, I. L., Young, R., Lefevre, L., Pridans, C., Tsang, H. G., Wu, C., Afrasiabi, C., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006997 · Cited by 175
“transcripts or of 5’ ends, for example in the horse [10], and in human and mouse by the 84 FANTOM 5 consortium [11-13], ENCODE project [14] and Genotype-Tissue Expression 85 (GTEx) Consortium [15].”
BackgroundSelf-citationWang, H.-L. V., & Chekanova, J. A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5203-3_5 · Cited by 170
Franceschini, N., Giambartolomei, C., de Vries, P. S., Finan, C., Bis, J. C., Huntley, R. P., Lovering, R. C., Tajuddin, S. M., Winkler, T. W., Graff, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07340-5 · Cited by 171
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Collaborators, G. S., Fachal, L., Collaborators, E., KConFab Investigators, HEBON Investigators, ABCTB Investigators, Aschard, H., Beesley, J., Barnes, D. R., Allen, J., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0537-1 · Cited by 174
Increased DNA methylation variability in type 1 diabetes across three immune effector cell types
Paul, D. S., Teschendorff, A. E., Dang, M. A. N., Lowe, R., Hawa, M. I., Ecker, S., Beyan, H., Cunningham, S., Fouts, A. R., Ramelius, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms13555 · Cited by 171
Yang, W., Feng, Y., Zhou, J., Cheung, O. K.-W., Cao, J., Wang, J., Tang, W., Tu, Y., Xu, L., Wu, F., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz6804 · Cited by 172
“In conjunction with RNA sequencing (RNA-seq) data using the same tumor and nontumor tissue pairs, we found 1626 target genes of the aggregated Functional ANnoTation Of the Mammalian genome 5 (FANTOM5)–designated enhancer regions (33) that were recurrently down-regulated in more than half of the HCCs examined (Fig.”
BackgroundVoisin, S., Almén, M. S., Zheleznyakova, G. Y., Lundberg, L., Zarei, S., Castillo, S., Eriksson, F. E., Nilsson, E. K., Blüher, M., Böttcher, Y., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0225-4 · Cited by 172
“Ubiquitous, tissue-specific (adipose tissue, blood, brain, liver, pancreas, and skeletal muscle) and cell typespecific (preadipocytes, fat cells, hepatocytes, and skeletal muscle cells) enhancers, as well as TSS–enhancer associations, as defined by CAGE tags in the FANTOM5 project, were downloaded from the Transcribed…”
BackgroundMethodInfluentialYin, X., Kim, K., Suetsugu, H., Bang, S.-Y., Wen, L., Koido, M., Ha, E., Liu, L., Sakamoto, Y., Jo, S., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219209 · Cited by 172
Self-citationNuclear stability and transcriptional directionality separate functionally distinct RNA species
Andersson, R., Refsing Andersen, P., Valen, E., Core, L. J., Bornholdt, J., Boyd, M., Heick Jensen, T., & Sandelin, A. (2014) · Nature Communications · doi:10.1038/ncomms6336 · Cited by 171
“348 (300) Novel promoters to stable mRNAs 65 (19) Novel promoters to stable lincRNAs 237 (122) Promoters to stable known lncRNAs”
BackgroundSelf-citationXiang, R., Berg, I. V. D., MacLeod, I. M., Hayes, B. J., Prowse-Wilkins, C. P., Wang, M., Bolormaa, S., Liu, Z., Rochfort, S. J., Reich, C. M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904159116 · Cited by 170
“This has been demonstrated in many studies of human genomics, including but not limited to the analysis of intermediate trait quantitative trait loci (QTLs), such as metabolic QTLs (mQTLs) (7) and expression QTLs (eQTLs) (8) and analysis of regulatory elements, such as promoters (9) and enhancers (10), which can be id…”
BackgroundTransposable elements in the mammalian embryo: pioneers surviving through stealth and service
Gerdes, P., Richardson, S. R., Mager, D. L., & Faulkner, G. J. (2016) · Genome Biology · doi:10.1186/s13059-016-0965-5 · Cited by 156
“In addition to bidirectional transcription denoting enhancer activity [68, 69], TE-derived enhancer sequences are enriched for bound Nanog, Sox2, Oct4, and the enhancer-related protein p300 [26].”
BackgroundDavie, K., Jacobs, J., Atkins, M., Potier, D., Christiaens, V., Halder, G., & Aerts, S. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004994 · Cited by 166
“Another, more recently discovered feature of active enhancers is that RNA, known as eRNA, is transcribed from them in a bidirectional way by RNApolII [4].”
BackgroundInfluentialStyrkarsdottir, U., Lund, S. H., Thorleifsson, G., Zink, F., Stefansson, O. A., Sigurdsson, J. K., Juliusson, K., Bjarnadottir, K., Sigurbjornsdottir, S., Jonsson, S., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0247-0 · Cited by 167
Mulder, R. H., Neumann, A., Cecil, C. A. M., Walton, E., Houtepen, L. C., Simpkin, A. J., Rijlaarsdam, J., Heijmans, B. T., Gaunt, T. R., Felix, J. F., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddaa280 · Cited by 165
“eosinophils or B cells (105), (iv) cis and trans meQTLs identified by the BIOS consortium (45) and polymorphic CpGs (46) and (v) inclusion in two well-known epigenetic age estimators (39,40).”
BackgroundThe core promoter: At the heart of gene expression
Danino, Y. M., Even, D., Ideses, D., & Juven-Gershon, T. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.04.003 · Cited by 164
“Although eRNAs are extensively investigated, also by high-scale methodologies [265], little is known about their core promoter compositions and their TSS architectures [55].”
BackgroundEnhancerAtlas: a resource for enhancer annotation and analysis in 105 human cell/tissue types
Gao, T., He, B., Liu, S., Zhu, H., Tan, K., & Qian, J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw495 · Cited by 163
“…(vii) The DNA sequences of enhancers could also be transcribed and these transcribed enhancer RNAs (eRNAs) are an indicator of active enhancers (Andersson et al. , 2014); (viii) Approaches to determine the three-dimensional conformation of chromosomes (e.g. 5C and ChIA-PET, Capture-C) are able…”
BackgroundInfluentialTranscriptional response to stress is pre-wired by promoter and enhancer architecture
Vihervaara, A., Mahat, D. B., Guertin, M. J., Chu, T., Danko, C. G., Lis, J. T., & Sistonen, L. (2017) · Nature Communications · doi:10.1038/s41467-017-00151-0 · Cited by 164
Quantitative gene profiling of long noncoding RNAs with targeted RNA sequencing
Clark, M. B., Mercer, T. R., Bussotti, G., Leonardi, T., Haynes, K. R., Crawford, J., Brunck, M. E., Cao, K.-A. L., Thomas, G. P., Chen, W. Y., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3321 · Cited by 163
Thomas, G. D., Hanna, R. N., Vasudevan, N. T., Hamers, A. A., Romanoski, C. E., McArdle, S., Ross, K. D., Blatchley, A., Yoakum, D., Hamilton, B. A., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.011 · Cited by 163
Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
Klinge, C. M. (2018) · Non-Coding RNA · doi:10.3390/ncrna4040040 · Cited by 163
“LncRNAs are defined as ncRNAs of >200 nucleotides [64].”
BackgroundLuo, Y., de Lange, K. M., Jostins, L., Moutsianas, L., Randall, J., Kennedy, N. A., Lamb, C. A., McCarthy, S., Ahmad, T., Edwards, C., et al. (2017) · Nature Genetics · doi:10.1038/ng.3761 · Cited by 162
Sen, A., Heredia, N., Senut, M.-C., Land, S., Hollocher, K., Lu, X., Dereski, M. O., & Ruden, D. M. (2015) · Scientific Reports · doi:10.1038/srep14466 · Cited by 162
Gogol-Döring, A., Ammar, I., Gupta, S., Bunse, M., Miskey, C., Chen, W., Uckert, W., Schulz, T. F., Izsvák, Z., & Ivics, Z. (2016) · Molecular Therapy · doi:10.1038/mt.2016.11 · Cited by 160
Partha, R., Chauhan, B. K., Ferreira, Z., Robinson, J. D., Lathrop, K., Nischal, K. K., Chikina, M., & Clark, N. L. (2017) · eLife · doi:10.7554/elife.25884 · Cited by 160
“…enhancers show strong convergent acceleration in subterranean mammals The FANTOM5 consortium has identified putative enhancer sites in the human and mouse genomes based on bidirectional enhancer transcription across tissues as well as at multiple developmental time points (Andersson et al., 2014).”
BackgroundMethodIntegrating Diverse Datasets Improves Developmental Enhancer Prediction
Erwin, G. D., Oksenberg, N., Truty, R. M., Kostka, D., Murphy, K. K., Ahituv, N., Pollard, K. S., & Capra, J. A. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003677 · Cited by 159
“The ENCODE project [26], FANTOM project [27], and similar studies focused on specific cell types [28,29] have dramatically increased the amount of publicly available functional genomics data.”
BackgroundSystematic analysis of binding of transcription factors to noncoding variants
Yan, J., Qiu, Y., Ribeiro dos Santos, A. M., Yin, Y., Li, Y. E., Vinckier, N., Nariai, N., Benaglio, P., Raman, A., Li, X., et al. (2021) · Nature · doi:10.1038/s41586-021-03211-0 · Cited by 158
Bell, C. G., Gao, F., Yuan, W., Roos, L., Acton, R. J., Xia, Y., Bell, J., Ward, K., Mangino, M., Hysi, P. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-01586-1 · Cited by 158
lncRNAfunc: a knowledgebase of lncRNA function in human cancer
Yang, M., Lu, H., Liu, J., Wu, S., Kim, P., & Zhou, X. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1035 · Cited by 184
“Gene promoter regions were defined as the overlap regions between upstream and downstream 2 kb of transcription start site and the promoter regions in FANTOM/ EPD for each gene.”
Vitamin D and Its Target Genes
Carlberg, C. (2022) · Nutrients · doi:10.3390/nu14071354 · Cited by 182
“Transcription factors, such as VDR, bind to enhancer regions [60], which are stretches of genomic DNA that contain specific binding sites (Section 2), for one or multiple transcription factors.”
BackgroundThe Hierarchy of Transcriptional Activation: From Enhancer to Promoter
Vernimmen, D., & Bickmore, W. A. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.10.004 · Cited by 155
Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia
Ott, C. J., Federation, A. J., Schwartz, L. S., Kasar, S., Klitgaard, J. L., Lenci, R., Li, Q., Lawlor, M., Fernandes, S. M., Souza, A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.001 · Cited by 153
Genomic modulators of gene expression in human neutrophils
Naranbhai, V., Fairfax, B. P., Makino, S., Humburg, P., Wong, D., Ng, E., Hill, A. V. S., & Knight, J. C. (2015) · Nature Communications · doi:10.1038/ncomms8545 · Cited by 153
“…approach, in which, despite vastly fewer regions, we observe 14-fold enrichment of neutrophil eQTL in neutrophil enhancer regions (p= 3.03×10 −15 ) and 6-fold enrichment of monocyte eQTL in monocyte enhancer regions (p=3.58×10 −17 ) using enhancer maps generated by CAGE-Seq in FANTOM5 47,48 .”
InfluentialGenomic Perspectives of Transcriptional Regulation in Forebrain Development
Nord, A. S., Pattabiraman, K., Visel, A., & Rubenstein, J. L. R. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.011 · Cited by 152
“…modifications, DNase hypersensitivity, enhancer [e]RNA, and DNA hypomethylation are in line with results from in vivo transgenic assays showing that enhancers are highly tissue-specific (Andersson et al., 2014; Shen et al., 2012; Stergachis et al., 2013; Visel et al., 2007; Zhu et al., 2013).”
Gothe, H. J., Bouwman, B. A. M., Gusmao, E. G., Piccinno, R., Petrosino, G., Sayols, S., Drechsel, O., Minneker, V., Josipović, N., Mizi, A., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.015 · Cited by 162
Li, B., & Ritchie, M. D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.713230 · Cited by 183
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
Ferrari, A., Vincent-Salomon, A., Pivot, X., Sertier, A.-S., Thomas, E., Tonon, L., Boyault, S., Mulugeta, E., Treilleux, I., MacGrogan, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms12222 · Cited by 150
“In addition, mutations were further annotated using FANTOM5 predictions 61 , which uses cap analysis of gene expression to detect potentially active transcription from promotor or enhancer regions.”
Constructing 3D interaction maps from 1D epigenomes
Zhu, Y., Chen, Z., Zhang, K., Wang, M., Medovoy, D., Whitaker, J. W., Ding, B., Li, N., Zheng, L., & Wang, W. (2016) · Nature Communications · doi:10.1038/ncomms10812 · Cited by 149
Mechanisms of tissue and cell-type specificity in heritable traits and diseases
Hekselman, I., & Yeger‐Lotem, E. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0200-9 · Cited by 161
Genetic drivers of m6A methylation in human brain, lung, heart and muscle
Xiong, X., Hou, L., Park, Y., Molinié, B., Ardlie, K., Aguet, F., Gregory, R. I., & Kellis, M. (2021) · Nature Genetics · doi:10.1038/s41588-021-00890-3 · Cited by 174
Cheng, F., Zhao, J., & Zhao, Z. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv068 · Cited by 161
“These projects include the Encyclopedia of DNA Elements (ENCODE) [21], NIH Roadmap Epigenomics [22] and the functional annotation of the mammalian genome 5 (FANTOM5) [23].”
BackgroundMethodSwitching on sex: transcriptional regulation of the testis-determining gene Sry
Larney, C., Bailey, T. L., & Koopman, P. A. (2014) · Development · doi:10.1242/dev.107052 · Cited by 179
Plant Enhancers: A Call for Discovery
Weber, B., Zicola, J., Oka, R., & Stam, M. E. (2016) · Trends in Plant Science · doi:10.1016/j.tplants.2016.07.013 · Cited by 168
Integrator is a genome-wide attenuator of non-productive transcription
Lykke-Andersen, S., Žumer, K., Molska, E. Š., Rouvière, J. O., Wu, G., Demel, C., Schwalb, B., Schmid, M., Cramer, P., & Jensen, T. H. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.014 · Cited by 162
Self-citationRizzardi, L. F., Hickey, P. F., Rodriguez DiBlasi, V., Tryggvadóttir, R., Callahan, C. M., Idrizi, A., Hansen, K. D., & Feinberg, A. P. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0297-8 · Cited by 146
Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer
Carter, H., Marty, R., Hofree, M., Gross, A. M., Jensen, J., Fisch, K. M., Wu, X., DeBoever, C., Van Nostrand, E. L., Song, Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1045 · Cited by 146
“Enhancer coordinates were obtained from Fantom 5 (74)(robust enhancer set).”
MethodHigh-throughput functional comparison of promoter and enhancer activities
Nguyen, T. A., Jones, R. D., Snavely, A. R., Pfenning, A. R., Kirchner, R., Hemberg, M., & Gray, J. M. (2016) · Genome Research · doi:10.1101/gr.204834.116 · Cited by 146
“…motifs Compared to the genome at large, promoters but not most distal enhancers have elevated frequencies of CpG dinucleotides (Heintzman et al. 2007; Deaton and Bird 2011; Andersson et al. 2014), whose presence at promoters also correlates with activity in reporter assays (Landolin et al. 2010).”
BackgroundInfluentialDiaferia, G. R., Balestrieri, C., Prosperini, E., Nicoli, P., Spaggiari, P., Zerbi, A., & Natoli, G. (2016) · The EMBO Journal · doi:10.15252/embj.201592404 · Cited by 163
“Thus, cell type-specific differences in the repertoire of genomic regions marked by such histone modifications reflect the underlying activity of different combinations of TFs (Heintzman et al , 2009; Visel et al , 2009; Andersson et al , 2014; Lara-Astiaso et al , 2014).”
Ligand-Dependent Enhancer Activation Regulated by Topoisomerase-I Activity
Puc, J., Kozbial, P., Li, W., Tan, Y., Liu, Z., Suter, T., Ohgi, K. A., Zhang, J., Aggarwal, A. K., & Rosenfeld, M. G. (2015) · Cell · doi:10.1016/j.cell.2014.12.023 · Cited by 143
“…are also transcription units, wherein their effect on target coding genes correlates with the transcription of the lncRNAs, referred to as eRNAs (Andersson et al., 2014; De Santa et al., 2010; Hah et al., 2013; Kaikkonen et al., 2013; Kim et al., 2010; Lai et al., 2013; Lam et al., 2013; Li et…”
Ogami, K., Richard, P., Chen, Y., Hoque, M., Li, W., Moresco, J. J., Yates, J. R., Tian, B., & Manley, J. L. (2017) · Genes & Development · doi:10.1101/gad.302604.117 · Cited by 141
“These include, for example, RNAs that are transcribed upstream of protein-coding gene promoters (Preker et al. 2008; Flynn et al. 2011) as well as RNAs transcribed, frequently bidirectionally, from transcriptional enhancers (Djebali et al. 2012; Andersson et al. 2014a).”
BackgroundSelf-citationEmerging Roles of Non-Coding RNA Transcription
Kaikkonen, M. U., & Adelman, K. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.06.002 · Cited by 158
Interpretation of deep learning in genomics and epigenomics
Talukder, A., Barham, C., Li, X., & Hu, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa177 · Cited by 142
“The interaction between different types of gene regulatory regions such as enhancers and promoters is critical to fully understanding gene transcriptional regulation [17–19,71,79–86].”
BackgroundFang, J., Zhang, P., Wang, Q., Chiang, C.-W., Zhou, Y., Hou, Y., Xu, J., Chen, R., Zhang, B., Lewis, S. J., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00951-z · Cited by 140
“The second data-set we used was from the Functional Annotation of the Mammalian Genome 5 (FANTOM5) project [22], in which cap analysis of gene expression (CAGE) technology was employed to infer enhancer-promoter links Comparison analyses were conducted to evaluate the predicted drug‑AD association…”
MethodNam, A. S., Dusaj, N., Izzo, F., Murali, R., Myers, R. M., Mouhieddine, T. H., Sotelo, J., Benbarche, S., Waarts, M., Gaiti, F., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01179-9 · Cited by 140
Core promoters in transcription: old problem, new insights
Roy, A. L., & Singer, D. S. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.01.007 · Cited by 139
Gene Regulatory Elements, Major Drivers of Human Disease
Chatterjee, S., & Ahituv, N. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035537 · Cited by 139
Chu, T., Rice, E. J., Booth, G. T., Salamanca, H. H., Wang, Z., Core, L. J., Longo, S. L., Corona, R. J., Chin, L. S., Lis, J. T., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0244-3 · Cited by 138
Zhao, A., Zhou, H., Yang, J., Li, M., & Niu, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01342-6 · Cited by 164
“Some enhancer loci can be translated into lncRNAs, which are known as enhancerassociated lncRNAs (elncRNAs).(539,540) ElncRNAs can promote target gene expression through the action of preexisting chromatin conformations(541) or through the recruitment of chromatin-activating complexes to the promoters of target genes.”
BackgroundMattioli, K., Volders, P.-J., Gerhardinger, C., Lee, J. C., Maass, P. G., Melé, M., & Rinn, J. L. (2019) · Genome Research · doi:10.1101/gr.242222.118 · Cited by 153
Human Promoters Are Intrinsically Directional
Duttke, S. H. C., Lacadie, S. A., Ibrahim, M. M., Glass, C. K., Corcoran, D. L., Benner, C., Heinz, S., Kadonaga, J. T., & Ohler, U. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.029 · Cited by 138
“…a ‘‘transcribed enhancer’’ state with H3K4me1/H3K4me2/ H3K27ac, which intersects strongly with enhancer-RNA-based definitions made by the FANTOM5 Consortium (Andersson et al., 2014) (Figure S6A); and a background state that does not show enrichment for any of the analyzed histone modifications…”
InfluentialWang, Q., Chen, R., Cheng, F., Wei, Q., Ji, Y., Yang, H., Zhong, X., Tao, R., Wen, Z., Sutcliffe, J. S., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0382-7 · Cited by 136
Epigenetic regulation of gene expression in cancer: techniques, resources and analysis
Kagohara, L. T., Stein-O’Brien, G., Kelley, D. Z., Flam, E. L., Wick, H. C., Danilova, L., Easwaran, H., Favorov, A. V., Qian, J. X., Gaykalova, D. A., et al. (2017) · Briefings in Functional Genomics · doi:10.1093/bfgp/elx018 · Cited by 149
Hing, B., Sathyaputri, L., & Potash, J. B. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32616 · Cited by 137
“…the function of non-coding regions, recent efforts by the Encyclopedia of DNA Elements (ENCODE) consortium and Functional Annotation of the Mammalian Genome (FANTOM) consortium have revealed a vast number of functionally important non-coding regions (Andersson et al., 2014; Dunham et al., 2012).”
BackgroundAmaral, P. P., Leonardi, T., Han, N., Viré, E., Gascoigne, D. K., Arias-Carrasco, R., Büscher, M., Pandolfini, L., Zhang, A., Pluchino, S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1405-5 · Cited by 136
“Interrogation of the FANTOM5 Consortium database [35], containing com-”
Epigenetic regulation of female puberty
Lomniczi, A., Wright, H., & Ojeda, S. R. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.08.003 · Cited by 136
Minderjahn, J., Schmidt, A., Fuchs, A., Schill, R., Raithel, J., Babina, M., Schmidl, C., Gebhard, C., Schmidhofer, S., Mendes, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13960-2 · Cited by 136
Self-citationCase for genome sequencing in infants and children with rare, undiagnosed or genetic diseases
Bick, D. P., Jones, M. C., Taylor, S. L., Taft, R. J., & Belmont, J. W. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106111 · Cited by 171
“49 50 The detection of coding CNVs that are smaller than three exons may require GS because pathogenic single-exon CNVs are frequently missed by ES analyses.”
DeepTACT: predicting 3D chromatin contacts via bootstrapping deep learning
Li, W., Wong, W. H., & Jiang, R. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz167 · Cited by 133
“In addition, we collected permissive enhancers from FANTOM5 (21) and extended the length of each enhancer to 2 kb surrounding its middle site, resulting in a list of 65 432 permissive enhancers.”
MethodeFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data
Breeze, C. E., Reynolds, A. P., van Dongen, J., Dunham, I., Lazar, J., Neph, S., Vierstra, J., Bourque, G., Teschendorff, A. E., Stamatoyannopoulos, J. A., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz456 · Cited by 133
Decoding mechanisms by which silent codon changes influence protein biogenesis and function
Bali, V., & Bebok, Z. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.03.011 · Cited by 133
“Some components of an mRNP complex may work by repressing translation until the appropriate cellular location is reached (Mitchell and Parker, 2014), while others may operate as cell- and tissue-specific enhancers (Andersson et al., 2014).”
Update on the genetic architecture of rheumatoid arthritis
Kim, K.-W., Bang, S., Lee, H., & Bae, S. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.176 · Cited by 143
The three-dimensional genome: regulating gene expression during pluripotency and development
Andrey, G., & Mundlos, S. (2017) · Development · doi:10.1242/dev.148304 · Cited by 130
Genome-wide association study identifies multiple susceptibility loci for glioma
Kinnersley, B., Labussière, M., Holroyd, A., Stefano, A. L. D., Broderick, P., Vijayakrishnan, J., Mokhtari, K., Delattre, J., Gousias, K., Schramm, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9559 · Cited by 138
A practical view of fine-mapping and gene prioritization in the post-genome-wide association era
Broekema, R. V., Bakker, O. B., & Jonkers, I. H. (2020) · Open Biology · doi:10.1098/rsob.190221 · Cited by 130
“Second, the effects of non-coding causal variants can be highly cell-type-, context- and disease-specific [9].”
BackgroundA comparison of gene expression and DNA methylation patterns across tissues and species
Blake, L. E., Roux, J., Hernando-Herraez, I., Banovich, N. E., García-Pérez, R., Hsiao, C. J., Eres, I. E., Chavarria, C., Marquès‐Bonet, T., & Gilad, Y. (2020) · Genome Research · doi:10.1101/gr.254904.119 · Cited by 152
“using CAGE-seq data on primary tissues [52].”
BackgroundBaillie, J. K., Arner, E., Daub, C., De Hoon, M., Itoh, M., Kawaji, H., Lassmann, T., Carninci, P., Forrest, A. R. R., Hayashizaki, Y., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006641 · Cited by 130
“Summary p-values for PLOS Genetics | DOI:10.1371/journal.pgen.1006641 March 6, 2017 27 / 36 this set of loci were computed using PASCAL [151] to calculate the total “burden of significance” within a range of +/-100kb from each TSS region, for each GWAS study, and then to quantify the probability of such a signal arisi…”
InfluentialSelf-citationWill, A. J., Cova, G., Osterwalder, M., Chan, W.-L., Wittler, L., Brieske, N., Heinrich, V., de Villartay, J.-P., Vingron, M., Klopocki, E., et al. (2017) · Nature Genetics · doi:10.1038/ng.3939 · Cited by 129
Charlet, J., Duymich, C. E., Lay, F. D., Mundbjerg, K., Dalsgaard Sørensen, K., Liang, G., & Jones, P. A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.033 · Cited by 128
“Enhancer activity also can be characterized by specific TF and co-factor binding, such as EP300 (Heintzman et al., 2007), and by RNAPII-mediated enhancer transcription of short bidirectional, unspliced RNAs (Andersson et al., 2014).”
Comprehensive comparative analysis of 5′-end RNA-sequencing methods
Adiconis, X., Haber, A. L., Simmons, S., Levy‐Moonshine, A., Ji, Z., Busby, M., Shi, X., Jacques, J., Lancaster, M. A., Pan, J. Q., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0014-2 · Cited by 139
“Because eRNAs are expressed at lower levels than mRNAs and are expressed as divergent, non-overlapping transcript pairs, we took a second approach based on a previous study 33 (Online Methods) to identifying peaks in such regions.”
Massively parallel cis-regulatory analysis in the mammalian central nervous system
Shen, S. Q., Myers, C. A., Hughes, A. E. O., Byrne, L. C., Flannery, J. G., & Corbo, J. C. (2016) · Genome Research · doi:10.1101/gr.193789.115 · Cited by 126
Andersson, R. (2015) · BioEssays · doi:10.1002/bies.201400162 · Cited by 127
“Subsequent studies have further refined the patterns of histone PTMs and identified specific chromatin states related to enhancer activity (Fig.”
BackgroundInfluentialSelf-citationTissue-Specific RNA Expression Marks Distant-Acting Developmental Enhancers
Wu, H., Nord, A. S., Akiyama, J. A., Shoukry, M., Afzal, V., Rubin, E. M., Pennacchio, L. A., & Visel, A. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004610 · Cited by 126
“CAGE analysis from human cell lines and tissues showed that incorporating enhancer expression data can increase the validation rate of ENCODE enhancer predictions and that bidirectional capped RNA signatures can in principle be used to identify de novo cell-specific enhancers [21].”
InfluentialrefTSS: A Reference Data Set for Human and Mouse Transcription Start Sites
Abugessaisa, I., Noguchi, S., Hasegawa, A., Kondo, A., Kawaji, H., Carninci, P., & Kasukawa, T. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.045 · Cited by 126
Self-citationDead Cas Systems: Types, Principles, and Applications
Brezgin, S. A., Kostyusheva, A. P., Kostyushev, D. S., & Chulanov, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236041 · Cited by 140
“Optimal sites of gRNA targeting for CLOuD9 can be selected in genomic browsers with the described considerations for distal regulatory regions annotated in FANTOM5 [65] and GeneHancer [43] databases.”
BackgroundMethodTranscription factor binding predicts histone modifications in human cell lines
Benveniste, D., Sonntag, H.-J., Sanguinetti, G., & Sproul, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412081111 · Cited by 126
“We used a dataset of ∼40,000 loci defined by the FANTOM5 consortium based on the presence of bidirectional capped transcripts in a set of 567 tissue and cell samples (24).”
MethodGriffon, A., Barbier, Q., Dalino, J., van Helden, J., Spicuglia, S., & Ballester, B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1280 · Cited by 124
“Indeed, recent studies have uncovered hundreds of genomic loci that are cooccupied by multiple TFs in various cell types suggesting the importance and abundance of combinatorial regulation in cells (2,7,8).”
BackgroundRegulatory functions of the Mediator kinases CDK8 and CDK19
Fant, C. B., & Taatjes, D. J. (2018) · Transcription · doi:10.1080/21541264.2018.1556915 · Cited by 143
“Whereas the human genome contains an estimated fifty- to sixty-thousand enhancers[50], only a subset of these will be “active” in any given cell type[51], and this is dependent upon chromatin structure and TF binding[52].”
Background
Metadata
- Authors
- The FANTOM Consortium, Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., Ntini, E., Arner, E., Valen, E., Li, K., Schwarzfischer, L., Glatz, D., Raithel, J., Lilje, B., Rapin, N., Bagger, F. O., Jørgensen, M., Andersen, P. R., Bertin, N., Rackham, O., Burroughs, A. M., Baillie, J. K., Ishizu, Y., Shimizu, Y., Furuhata, E., Maeda, S., Negishi, Y., Mungall, C. J., Meehan, T. F., Lassmann, T., Itoh, M., Kawaji, H., Kondo, N., Kawai, J., Lennartsson, A., Daub, C. O., Heutink, P., Hume, D. A., Jensen, T. H., Suzuki, H., Hayashizaki, Y., Müller, F., Forrest, A. R. R., Carninci, P., Rehli, M., & Sandelin, A.
- Affiliations
- University of Copenhagen (DK)
- University Hospital Regensburg (DE)
- University of Birmingham (GB)
- University of North Carolina at Chapel Hill (US)
- RIKEN (JP)
- Aarhus University (DK)
- Roslin Institute (GB)
- European Bioinformatics Institute (GB)
- Karolinska Institutet (SE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- ORCID
- Andersson, Robin
- Gebhard, Claudia
- Miguel-Escalada, Irene
- Hoof, Ilka
- Bornholdt, Jette
- Chen, Yun
- Schmidl, Christian
- Suzuki, Takahiro
- Ntini, Evgenia
- Valen, Eivind
- Li, Kang
- Lilje, Berit
- Rapin, Nicolas
- Bagger, Frederik Otzen
- Andersen, Peter Refsing
- Bertin, Nicolas
- Rackham, Owen
- Burroughs, A. Maxwell
- Baillie, J. Kenneth
- Ishizu, Yuri
- Shimizu, Yuri
- Furuhata, Erina
- Meehan, Terrence F.
- Lassmann, Timo
- Itoh, Masayoshi
- Kawaji, Hideya
- Kawai, Jun
- Lennartsson, Andreas
- Daub, Carsten O.
- Heutink, Peter
- Hume, David A.
- Jensen, Torben Heick
- Suzuki, Harukazu
- Hayashizaki, Yoshihide
- Müller, Ferenc
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- Venue
- Nature
- Published
- 2014-03
- Volume
- 507
- Issue
- 7493
- Pages
- 455-461
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5215096
- OpenAlex
- W2015845481
- Cited by
- 2,550
- References
- 81
- Citations by year
- 2026: 93 · 2025: 140 · 2024: 207 · 2023: 185 · 2022: 225 · 2021: 280 · 2020: 232 · 2019: 226 · 2018: 261 · 2017: 208 · 2016: 186 · 2015: 212 · 2014: 89
- FWCI
- 95.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- PubMed Central (acceptedVersion)
- SDL (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Wellcome Trust (103258/Z/13/Z)
- European Commission (FP7/2007–2013/ERC, 2007–2013, FP7 2007-2013, FP7/2007)
- Deutsche Forschungsgemeinschaft (FP7/2007–2013)
- Ministry of Education, Culture, Sports, Science and Technology
- Lundbeckfonden (R167-2013-15058, R82-2010-6779)
- Novo Nordisk
- Novo Nordisk Fonden (NNF12OC0001211)
- H. Lundbeck A/S
- Biotechnology and Biological Sciences Research Council (BBS/E/D/20251969, BB/I024801/1)
- Japan Society for the Promotion of Science (24659373, 25330333, 22228005)
- RIKEN
- National Institute of Dental and Craniofacial Research (R01DE022969)
- FP7 Ideas: European Research Council (204135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- enhancers, bidirectional transcription, unspliced RNA, FANTOM5, CAGE, cell type-specific gene regulation, regulatory single nucleotide polymorphisms, enhancer redundancy, transcription start sites, promoter usage, human cell types, tissue-specific enhancers
- MeSH terms
- Atlases as Topic, Cell Line, Cells, Cultured, Enhancer Elements, Genetic, Gene Expression Regulation, HeLa Cells, Humans, Organ Specificity, Promoter Regions, Genetic, RNA, Messenger, Cluster Analysis, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Transcription Initiation Site, Molecular Sequence Annotation, Transcription Initiation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.